Engaging Diverse Underserved Communities to Bridge the Mammography Divide
1 other identifier
interventional
261
1 country
1
Brief Summary
Breast cancer is the second most common cause of cancer death in the U.S.1 in spite of being preventable, easily detectable, and curable.2-11 Breast screening continues to be underutilized by the general population and especially by traditionally underserved minority populations. Two of the least screened minority groups are American Indians/Alaska Natives (AI/AN) and Latinas. American Indian/Alaska Native women have the poorest recorded 5-year cancer survival rates of any ethnic group and the lowest (or near-lowest) screening rates for major cancers.12 Furthermore, breast cancer is the number one cause of cancer mortality among Latina women.13 While breast cancer screening rates have increased nationally, there has been an increase in the gap in breast cancer screening utilization between individuals from minority versus majority racial/ethnic groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Sep 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2010
CompletedFirst Submitted
Initial submission to the registry
December 21, 2010
CompletedFirst Posted
Study publicly available on registry
December 24, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2015
CompletedSeptember 16, 2015
September 1, 2015
4.8 years
December 21, 2010
September 15, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
120-day post randomization mammography screening completion
To compare the 120-day post randomization mammography screening completion rates of individuals who receive a computerized mammography "implementation intentions" (MI2) intervention, versus a comparison computerized condition of general breast cancer prevention health education (C).
day 120
Secondary Outcomes (2)
To compare the screening mammography self-reported barriers after 120-days post randomization
day 120
To compare changes in mammography screening Precaution Adoption Process Model
day 120
Study Arms (2)
Intervention
EXPERIMENTALControl
ACTIVE COMPARATORInterventions
For persons who are randomized to the MI2 intervention arm, the HLK-BH program will guide participants through a series of questions to fully delineate step-by-step breast cancer screening intentions of participants the when, where and how of screening)and encourage follow through on these intentions.
Each participant in the C intervention arm will receive the same brief one-on-one breast cancer screening education information delivered in person by a CHW as MI2 participants. In additional participants will go through the Healthy Living Kansas-Breast Health computerized screening and intervention program.
Eligibility Criteria
You may qualify if:
- Latina or AI/AN woman residing in one of participating communities
- Aged ≥40 years of age
- Not up to date on mammography screening
- Home address \& access to a working telephone
- Responded to 120-day post randomization follow-up call
You may not qualify if:
- Receipt of mammogram within past year
- Acute medical illness, history of breast cancer, 1st
- Cognitive impairment or inappropriate affect or behavior
- Another household member enrolled in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
Related Publications (1)
Engelman KK, Cupertino AP, Daley CM, Long T, Cully A, Mayo MS, Ellerbeck EF, Geana MV, Greiner A. Engaging diverse underserved communities to bridge the mammography divide. BMC Public Health. 2011 Jan 21;11:47. doi: 10.1186/1471-2458-11-47.
PMID: 21255424DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Kimberly Engelman, PhD
University of Kansas Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 21, 2010
First Posted
December 24, 2010
Study Start
September 1, 2010
Primary Completion
June 1, 2015
Study Completion
August 1, 2015
Last Updated
September 16, 2015
Record last verified: 2015-09